Bioavailable Androgen Levels quantify the circulating concentration of androgens, predominantly testosterone and dihydrotestosterone (DHT), that are loosely bound to albumin and the small fraction that is completely unbound (free). This combined measurement represents the pool of hormone that can easily dissociate from binding proteins and become accessible to target tissues. This metric is a more accurate clinical indicator of androgen action than total testosterone, especially when Sex Hormone-Binding Globulin (SHBG) levels are abnormal.
Origin
This term developed in clinical endocrinology to address the limitations of total hormone testing, recognizing that SHBG-bound hormones are largely inert. The concept is a practical compromise between measuring only the very small free fraction and the often misleading total level. It offers a clearer picture of the hormone available for biological effect.
Mechanism
Albumin-bound androgens, unlike SHBG-bound androgens, bind weakly enough to dissociate readily at the capillary level, making them biologically available to diffuse into target cells. The measurement, often determined via calculation using total testosterone, albumin, and SHBG values, reflects this dynamic equilibrium. Adequate bioavailable levels are essential for maintaining muscle mass, bone density, libido, and neurocognitive function by ensuring sufficient ligand is present to activate androgen receptors.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.